201 related articles for article (PubMed ID: 36239872)
1. Short- and long-term outcomes in ypT2 rectal cancer patients after neoadjuvant therapy and local excision: a multicentre observational study.
Peltrini R; Castiglioni S; Imperatore N; Ortenzi M; Rega D; Romeo V; Caracino V; Liberatore E; Basti M; Santoro E; Bracale U; Delrio P; Mucilli F; Guerrieri M; Corcione F
Tech Coloproctol; 2023 Jan; 27(1):53-61. PubMed ID: 36239872
[TBL] [Abstract][Full Text] [Related]
2. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
[TBL] [Abstract][Full Text] [Related]
3. Transanal Endoscopic Microsurgery for Early Rectal Cancer: A Single-Center Experience.
O'Neill CH; Platz J; Moore JS; Callas PW; Cataldo PA
Dis Colon Rectum; 2017 Feb; 60(2):152-160. PubMed ID: 28059911
[TBL] [Abstract][Full Text] [Related]
4. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
5. Local excision for ypT2 rectal cancer following preoperative chemoradiation therapy: it should not be justified.
Yang KM; Lim SB; Lee JL; Kim CW; Yoon YS; Park IJ; Yu CS; Kim JC
Int J Colorectal Dis; 2018 Apr; 33(4):487-491. PubMed ID: 29468352
[TBL] [Abstract][Full Text] [Related]
6. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J
Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
[TBL] [Abstract][Full Text] [Related]
8. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
9. Transanal local excision versus intersphincteric resection for low rectal cancer with stage ypT0-1ycN0 after neoadjuvant chemoradiotherapy: an inverse probability weighting analysis for oncological and functional outcomes.
Pan H; Gao Y; Ruan H; Chi P; Huang Y; Huang S
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17383-17394. PubMed ID: 37843558
[TBL] [Abstract][Full Text] [Related]
10. Local excision for ypT2 rectal cancer--much ado about something.
Perez RO; Habr-Gama A; Proscurshim I; Campos FG; Kiss D; Gama-Rodrigues J; Cecconello I
J Gastrointest Surg; 2007 Nov; 11(11):1431-8; discussion 1438-40. PubMed ID: 17805938
[TBL] [Abstract][Full Text] [Related]
11. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
[TBL] [Abstract][Full Text] [Related]
12. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer.
Stipa F; Picchio M; Burza A; Soricelli E; Vitelli CE
Dis Colon Rectum; 2014 Nov; 57(11):1245-52. PubMed ID: 25285690
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study).
Verseveld M; de Graaf EJ; Verhoef C; van Meerten E; Punt CJ; de Hingh IH; Nagtegaal ID; Nuyttens JJ; Marijnen CA; de Wilt JH;
Br J Surg; 2015 Jun; 102(7):853-60. PubMed ID: 25847025
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer.
González JEB; Lavernia HC; Fraga JGP; Lemus SQ
Surg Endosc; 2022 May; 36(5):2906-2913. PubMed ID: 34231071
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer.
Borschitz T; Wachtlin D; Möhler M; Schmidberger H; Junginger T
Ann Surg Oncol; 2008 Mar; 15(3):712-20. PubMed ID: 18163173
[TBL] [Abstract][Full Text] [Related]
17. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study.
Liao YT; Lin YL; Huang J; Hung JS; Lin BR
Int J Colorectal Dis; 2021 Mar; 36(3):509-516. PubMed ID: 33128083
[TBL] [Abstract][Full Text] [Related]
18. Preservation of the rectum is possible in early rectal cancer with neoadjuvant radiotherapy, delay and local excision-a 12-year single-centre experience of the evolution of early rectal cancer treatment.
Bilkhu A; Robinson JM; Steward MA
Colorectal Dis; 2021 Jul; 23(7):1765-1776. PubMed ID: 33724612
[TBL] [Abstract][Full Text] [Related]
19. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
[TBL] [Abstract][Full Text] [Related]
20. Transanal endoscopic operation for rectal cancer after neoadjuvant therapy.
Rocha JJ; Bernardes MV; Feitosa MR; Perazzoli C; Machado VF; Peria FM; Oliveira HF; Feres O
Acta Cir Bras; 2016; 31 Suppl 1():29-33. PubMed ID: 27142902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
